

Meet ourLeaders
Leadership Team
Cytokinetics is led by a team of seasoned industry veterans with the shared objective to create the next great biopharmaceutical company that has the potential to change patients’ lives. With significant depth of industry experience and highly complementary skills in diverse fields including drug discovery, clinical research, business development, and commercialization, we’re ready to address the challenges and opportunities of creating an organization committed to helping those affected by serious diseases.
Cytokinetics was founded by pioneers in the field of muscle biology. This team of forward-thinking scientists set out a vision for translating their expertise into new insights and approaches to novel drug discovery. Over the years, the Company has developed an unparalleled expertise, keeping it at the forefront of drug discovery and development for diseases impacting muscle performance.
Our MANAGEMENT TEAM
filter by:-
Robert I. Blum
President And Chief Executive Officer
-
Andrew Callos
EVP, Chief Commercial Officer
-
Daniel R. Casper
VP, Information Technology
-
Bonnie A. Charpentier, Ph.D.
SVP, Regulatory Affairs and Compliance
-
Steven M. Cook
SVP, Commercial Supply Chain Operations
-
YulyMae DiNapoli
VP, Human Resources
-
Erin Donnelly
VP, Portfolio & Project Management
-
John Faurescu, Esq.
Associate General Counsel
-
Stephen B. Heitner, M.D.
VP, Clinical Research & Therapeutic Area Lead, Cardiovascular
-
Ching W. Jaw
SVP, Chief Financial Officer
-
Scott R. Jordan
SVP, Global Marketing & Commercial Strategy
-
Daniel E. Kates, M.D., M.B.A.
VP, Medical Affairs
-
Stuart Kupfer, M.D.
SVP, Chief Medical Officer
-
Kari K. Loeser, J.D.
VP, Chief Compliance Officer
-
Jeff Lotz
VP, Sales and Operations
-
Fady I. Malik, M.D., Ph.D.
EVP, Research and Development
-
Lisa Meng, Ph.D.
VP, Biometrics
-
Bradley P. Morgan, Ph.D.
SVP, Research and Non-Clinical Development
-
Anne N. Murphy, Ph.D.
VP, Biology
-
Diann Potestio
VP, Global Value, Access & Distribution
-
Stacy A. Rudnicki, M.D.
VP, Clinical Research & Therapeutic Area Lead, Neuromuscular
-
Elisabeth A. Schnieders, Ph.D.
SVP, Business Development
-
Eric Terhaerdt
SVP, Development Operations
-
Norma Tom, Ph.D.
VP, Chemistry, Manufacturing and Control
-
Diane Weiser
SVP, Corporate Communications and Investor Relations
-
Andrew A. Wolff, M.D., FACC
SVP, Senior Fellow, Clinical Research and Development
-
Robert C. Wong
VP, Chief Accounting Officer
-
Robert I. Blum
Director
-
Muna Bhanji
Director
-
Santo J. Costa
Director
-
Robert A. Harrington, M.D.
Director
-
John T. Henderson, M.B., Ch.B.
Chairman
-
Edward M. Kaye, M.D.
Director
-
B. Lynne Parshall, Esq
Director
-
Sandford D. Smith
Director
-
Wendell Wierenga, Ph.D.
Director
-
Nancy J. Wysenski
Director